Search for: "Matter of Roche"
Results 321 - 340
of 415
Sorted by Relevance
|
Sort by Date
12 Apr 2011, 3:50 pm
Hoffman-La Roche, Inc., 2009 WL 614484, *23 (N.J.Super.A.D. 2009). [read post]
19 Oct 2011, 3:30 am
(The SPC Blog) Portugal: Lisbon Commercial Court (first instance) revokes INPI decision which had rejected the registration IMUNID due to the existence of likelihood of confusion with previous CTM IMMUNIQ, both referring to “Dietetic substances adapted for medical use” (Class 46) Portugal: Pharmaceutical patent litigation in Portugal (PatLit) South Africa: TK legislation in the new tradition (IP Watch) US: FDA approval of biologics under 505(b)(2) expected to increase (Patent Docs) US:… [read post]
8 Jan 2020, 7:23 am
Roche Molecular Systems. [read post]
30 Aug 2012, 6:38 am
Hoffman-La Roche, Inc., 36 A.3d 541, 544 (N.J. 2012). [read post]
22 Mar 2012, 2:59 am
Moreover, the State’s obligations in matters of freedom of the press include the elimination of barriers to the exercise of press functions where, in issues of public interest, such barriers exist solely because of an information monopoly held by the authorities. [read post]
15 Sep 2011, 5:00 am
Matters that are “common knowledge to all doctors” need not be warned of at all. [read post]
7 Jun 2011, 11:06 am
Hoffmann-La Roche Inc., 541 F.3d. 1115, 1126 (Fed. [read post]
19 Feb 2010, 4:37 am
Law firm valuation (Michael Roch); 10. [read post]
13 May 2009, 8:00 pm
Under this interpretation, live, human-made micro-organisms (as well as isolated nucleotide sequences) were deemed patentable subject matter under § 101. [read post]
10 Jun 2009, 10:00 pm
The adequacy of a warning directed to physicians is such a matter. [read post]
3 May 2016, 1:42 am
Bancorp, et al., No. 15-591 (Whether subject matter eligibility under 35 U.S.C. [read post]
12 Sep 2021, 3:10 am
Insofar as points of law are concerned, this also applies, for instance, to the question of whether the subject-matter of a property right was obvious in the light of prior art. [read post]
20 Jul 2023, 1:42 am
Inventive step or sufficiency, why does it matter? [read post]
12 Oct 2018, 1:24 pm
And while “[t]he determination of obviousnessis made with respect to the subject matter as awhole, not separate pieces of the claim,” SanofiSynthelabov. [read post]
15 Apr 2020, 6:38 am
For starters, the timing of when a patient receives the test matters. [read post]
12 Feb 2009, 10:42 am
Hoffman-La Roche, Inc., 618 N.W.2d 827, 837 (Neb. 2000); Bish v. [read post]
22 Feb 2008, 6:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included:The European call for copyright extension for performers: (John Carroll), (The IP Factor), (Spicy IP), (Public Knowledge), (IPR-Helpdesk), (Techdirt), (Innovationpartners),Full CAFC to reexamine the scope of subject matter patentability for business methods, also to consider whether it is appropriate to reconsider or overrule State Street Bank… [read post]
19 Mar 2014, 9:00 am
According to an earlier “very broad order” obtained by Janssen, several matters had been bifurcated in the action, leaving only validity and infringement to be decided by Justice Hughes. [read post]
4 Feb 2010, 5:44 am
Hoffman-La Roche Inc., No. [read post]
11 Mar 2010, 12:28 pm
Also, the Commission did not, as Ajinomoto asserts, require the disclosure of all subject matter having to do with the claim term “bacterium. [read post]
